References
- Park YB, Lee SK. Leflunomide: a new disease modifying anti-rheumatic drug. J Korean Rheum Assoc 2000;7: 323-32
- Kalden JR, Schattenkirchner M, Sörensen H, Emery P, Deighton C, Rozman B, et al. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study. Arthritis Rheum 2003; 48:1513-20 https://doi.org/10.1002/art.11015
- Chikura B, Lane S, Dawson JK. Clinical expression of leflunomide-induced pneumonitis. Rheumatology (Oxford). Forthcoming 2009
- Savage RL, Highton J, Boyd IW, Chapman P. Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports. Intern Med J 2006; 36:162-9 https://doi.org/10.1111/j.1445-5994.2006.01035.x
- Lee JH, Cheon WS, Seo YI, Eom KS, Jang SH, Bahn JW, et al. A case of interstitial pneumonitis caused by leflunomide. Tuberc Respir Dis 2005;58:83-8 https://doi.org/10.4046/trd.2005.58.1.83
- Sheen DH, Lim MK, Shim SC, Lee SO, Kang SW, Song JK, et al. Successful treatment of interstitial pneumonitis induced by leflunomide. J Korean Rheum Assoc 2007; 14:268-73 https://doi.org/10.4078/jkra.2007.14.3.268
- Breedveld FC, Dayer JM. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis 2000;59:841-9 https://doi.org/10.1136/ard.59.11.841
- Bartlett RR, Brendel S, Zielinski T, Schorlemmer HU. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis. Transplant Proc 1996;28:3074-8
- McCurry J. Japan deaths spark concerns over arthritis drug. Lancet 2004;363:461
- Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol 1987; 14:1164-71
- Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum 2006;54:1435-9 https://doi.org/10.1002/art.21806
- Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, et al. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. J Rheumatol 2004;31:1521-31
- Vallbracht II, Popper HH, Rieber J, Nowak F, Gallenberger S, Piper B, et al. Lethal pneumonitis under leflunomide therapy. Rheumatology (Oxford) 2005;44: 1580-1 https://doi.org/10.1093/rheumatology/kei076
- Chikura B, Sathi N, Lane S, Dawson JK. Variation of immunological response in methotrexate-induced pneumonitis. Rheumatology (Oxford) 2008;47:1647-50 https://doi.org/10.1093/rheumatology/ken356